trial · primary record
Rifaximin SSD
Hepatic Encephalopathy
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 517 |
| Primary completion | 2026-02-24 |
| Primary endpoint | Time to First Event of Overt Hepatic Encephalopathy (OHE) Requiring Medical Intervention in the Hospital/Emergency Room (ER)/Emergency Department (ED)/Clinic or Death |
| Registry ID | NCT05297448 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:27.839Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05297448
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.